These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 36843132

  • 1. Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine.
    Schneider BK, Ward J, Sotillo S, Garelli-Paar C, Guillot E, Prikazsky M, Mochel JP.
    Sci Rep; 2023 Feb 26; 13(1):3300. PubMed ID: 36843132
    [Abstract] [Full Text] [Related]

  • 2. Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs.
    Sotillo S, Ward JL, Guillot E, Domenig O, Yuan L, Smith JS, Gabriel V, Iennarella-Servantez CA, Mochel JP.
    Sci Rep; 2023 Feb 15; 13(1):2684. PubMed ID: 36792677
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronobiology and Pharmacologic Modulation of the Renin-Angiotensin-Aldosterone System in Dogs: What Have We Learned?
    Mochel JP, Danhof M.
    Rev Physiol Biochem Pharmacol; 2015 Feb 15; 169():43-69. PubMed ID: 26428686
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
    Ames MK, Atkins CE, Eriksson A, Hess AM.
    J Vet Cardiol; 2017 Jun 15; 19(3):218-227. PubMed ID: 28576479
    [Abstract] [Full Text] [Related]

  • 8. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC, Ames MK, Werre S, Atkins CE.
    J Vet Pharmacol Ther; 2015 Oct 15; 38(5):513-7. PubMed ID: 25771846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP, Fink M, Peyrou M, Soubret A, Giraudel JM, Danhof M.
    Pharm Res; 2015 Jun 15; 32(6):1931-46. PubMed ID: 25446774
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.
    Expert Opin Pharmacother; 2007 Apr 15; 8(5):529-35. PubMed ID: 17376010
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST).
    Coffman M, Guillot E, Blondel T, Garelli-Paar C, Feng S, Heartsill S, Atkins CE.
    J Vet Intern Med; 2021 Jul 15; 35(4):1673-1687. PubMed ID: 34028078
    [Abstract] [Full Text] [Related]

  • 13. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
    Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Cabrini G, Bonizzato A, Graziani M, Anker SD, Coats AJ, Zardini P.
    J Am Coll Cardiol; 2001 Jun 01; 37(7):1808-12. PubMed ID: 11401115
    [Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D, Atkins C, Domenig O, DeFrancesco T, Keene B, Tou S, Stern JA, Meurs KM.
    J Vet Intern Med; 2020 Mar 01; 34(2):600-606. PubMed ID: 32112596
    [Abstract] [Full Text] [Related]

  • 15. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Mar 01; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.
    Ames MK, Atkins CE, Lantis AC, zum Brunnen J.
    J Renin Angiotensin Aldosterone Syst; 2016 Mar 01; 17(1):1470320316633897. PubMed ID: 27009288
    [Abstract] [Full Text] [Related]

  • 17. Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation.
    Mochel JP, Teng CH, Peyrou M, Giraudel J, Danhof M, Rigel DF.
    Eur J Pharm Sci; 2019 Feb 01; 128():103-111. PubMed ID: 30508581
    [Abstract] [Full Text] [Related]

  • 18. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M, Flannery A, Ferreira JP, Cheng MP, Kronfli N, Marelli A, Zannad F, Brophy J, Afillalo J, Huynh T, Giannetti N, Bessissow A, Ezekowitz JA, Lopes RD, Ambrosy AP, Craig M, Sharma A.
    Trials; 2021 Feb 05; 22(1):115. PubMed ID: 33546734
    [Abstract] [Full Text] [Related]

  • 19. Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
    Adin D, Atkins C, Wallace G, Klein A.
    J Vet Intern Med; 2021 May 05; 35(3):1245-1254. PubMed ID: 33713485
    [Abstract] [Full Text] [Related]

  • 20. Retrospective evaluation of a dose-dependent effect of angiotensin-converting enzyme inhibitors on long-term outcome in dogs with cardiac disease.
    Ward JL, Chou YY, Yuan L, Dorman KS, Mochel JP.
    J Vet Intern Med; 2021 Sep 05; 35(5):2102-2111. PubMed ID: 34387901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.